In this episode of Molecule to Market, you’ll go inside the outsourcing space of the global drug development sector with 20+ CEO and C-suite leaders from the CDMO ecosystem, exploring the overlooked trends for 2026.
- Nick Fortin, CEO, Codis
- Ankit Gupta, CEO, InstaPill
- Eric Edwards, MD, PhD, CEO, Phlow USA
- Dirk T. Lange, CEO, Pyramid Pharma Services
- Kaan-Fabian Kekec, Partner, Simon-Kucher Healthcare and Life Sciences
- J.D. Mowery, President, CDMO Division, Bora Pharmaceuticals
- Matthew Bio, CSO, Cambrex and President, Snapdragon Chemistry
- Bill Vincent, Biotech Entrepreneur, CEO and Board Member
- Philip Macnabb, CEO, Curia
- Christiane Bardroff, COO Leader
- Jason Anderson, CEO, Ensera
- Mark B, Anonymous CEO (not to be quoted by name)
- Adam Siebert, Managing Director, L.E.K. Consulting
- Stephen Dilly, CEO, Sonoma Biotherapeutics
- Elisabeth Stampa, CEO, Medichem
- Jon Alberdi, CEO, Vivebiotech
- Derek Hennecke, Founder, Investor and Board Member
- Bruce Thompson, CTO, Kincell Bio
Molecule to Market is also sponsored by Bora Pharmaceuticals, and supported by Lead Candidate. Please subscribe, tell your industry colleagues and join us in celebrating and promoting the value and importance of the global life science outsourcing space. We’d also appreciate a positive rating!
